Tim Bohen’s Top Trade Idea

A 200%+ winner today! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [StocksToTrade Live]( Top Trade Ideas From The Trading Desk of Tim Bohen Oracle delivered us another huge gainer today, even bigger than yesterday’s… Kazia Therapeutics Limited ADR (NASDAQ: KZIA) started running this morning on[news of positive drug trial data](. Oracle caught it early on and alerted us with a green buy signal and entry price of $0.35 per share. It spiked and topped out $1.08 for a whopping 208.57% gain*! Want to know how Oracle, our algorithmic tool, identifies massive winners like KZIA? Tune in to my [free live webinar]( tonight at 9 p.m. Eastern, where I’ll explain it all. Although not as big but just as impressive was the return in Virpax Pharmaceuticals Inc. (NASDAQ: VRPX). VRPX is another biotech company that started spiking on [good news from a drug study](. Oracle gave us the green entry price of $2.31 per share and it popped from there. After hitting its high of $3.39, it had returned 46.75%*. For tomorrow, I have Shopify Inc. (NYSE: SHOP) on my radar. Take a look at where it’s headed towards the close today… Shopify Inc. (NYSE: SHOP) If this thing retests recent resistance and then dips, we might get an Oracle green buy signal. Stay tuned… Hear about all the other Oracle winners from today and what else I’m watching tomorrow during my [Free live training webinar tonight at 9 pm Eastern.]( To your success, StocksToTrade Team   [Click Here to Unsubscribe]( 13809 Research Boulevard, Suite 500, Austin, TX 78750 Past performance does not indicate future results This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com